Here are four takeaways:
1. Dr. Schimpff is the founding director of Baltimore-based University of Maryland Greenebaum Cancer Center.
2. As University of Maryland Medical Center’s COO and CEO, Dr. Schimpff was in charge of 5,000 staff and 650 residents, as well as oversaw an annual budget of more than $1 billion to treat nearly 40,000 patients each year.
3. Renowned for his research about the causes, prevention and treatment of infection in cancer patients undergoing cancer therapy, Dr. Schimpff has authored more than 200 scientific articles, book chapters and reviews.
4. Dr. Schimpff has worked as a clinician and researcher with the National Cancer Institute.
“Patient Safe is very pleased to have Dr. Schimpff on the Company’s Board,” said Larry Gerrans, founder and chairman, Patient Safe. “Dr. Schimpff brings a wealth of scientific knowledge, industry expertise and business acumen to Patient Safe. His achievements in science and medicine place him among the elite intellectuals and leaders of our time. We appreciate Dr. Schimpff’s willingness to serve and look forward to benefiting from his experience and wise counsel.”
More articles on quality & infection control:
The value of an apology — 5 points on what patients want after a medical error
Commonwealth Informatics adds Dr. Trevor Gibbs to executive team: 4 notes
Sepsis enters spotlight with Patty Duke’s death: 6 things to know
